Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

Arthritis Research and Therapy

Volumn 11, Issue 3, 2009, Pages

  Miceli Richard, Corinne ^a,b   Gestermann, Nicolas ^b   Amiel, Corinne ^c   Sellam, Jérémie ^a,b   Ittah, Marc ^b   Pavy, Stephan ^a   Urrutia, Alejandra ^b   Girauld, Isabelle ^b   Carcelain, Guislaine ^d   Venet, Alain ^b   Mariette, Xavier ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL TENON   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; ETANERCEPT; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INFLIXIMAB; METHOTREXATE; PEPTIDE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARCINOGENESIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; DRUG EXPOSURE; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; RHEUMATOID ARTHRITIS; RISK FACTOR; SPONDYLOARTHROPATHY; TREATMENT DURATION; VIRUS LOAD; AGED; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; T LYMPHOCYTE; VIROLOGY;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; LONGITUDINAL STUDIES; METHOTREXATE; MIDDLE AGED; SPONDYLARTHROPATHIES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 67649449359     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2708     Document Type: Article

References (31)

1. Smedby KE Hjalgrim H Askling J Chang ET Gregersen H Porwit-MacDonald A Sundstrom C Akerman M Melbye M Glimelius B Adami HO Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype J Natl Cancer Inst 2006, 98:51-60. 16391371
2. Landgren O Engels EA Pfeiffer RM Gridley G Mellemkjaer L Olsen JH Kerstann KF Wheeler W Hemminki K Linet MS Goldin LR Autoimmunity and susceptibility to Hodgkin lymphoma: A population-based case-control study in Scandinavia J Natl Cancer Inst 2006, 98:1321-1330. 16985251
3. Kamel OW Rijn van de M Weiss LM Del Zoppo GJ Hench PK Robbins BA Montgomery PG Warnke RA Dorfman RF Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 1993, 328:1317-1321. 10.1056/NEJM199305063281806 8385742
4. Salloum E Cooper DL Howe G Lacy J Tallini G Crouch J Schultz M Murren J Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases J Clin Oncol 1996, 14:1943-1949. 8656264
5. Bongartz T Sutton AJ Sweeting MJ Buchan I Matteson EL Montori V Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 2006, 295:2275-2285. 10.1001/jama.295.19.2275 16705109
6. Baecklund E Iliadou A Askling J Ekbom A Backlin C Granath F Catrina AI Rosenquist R Feltelius N Sundstrom C Klareskog L Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis Arthritis Rheum 2006, 54:692-701. 10.1002/art.21675 16508929
7. Wolfe F Michaud K Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients Arthritis Rheum 2004, 50:1740-1751. 10.1002/art.20311 15188349
8. Geborek P Bladstrom A Turesson C Gulfe A Petersson IF Saxne T Olsson H Jacobsson LT Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas Ann Rheum Dis 2005, 64:699-703. 1755491 15695534 10.1136/ard.2004.030528
9. Schiff MH Burmester GR Kent JD Pangan AL Kupper H Fitzpatrick SB Donovan C Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis Ann Rheum Dis 2006, 65:889-894. 10.1136/ard.2005.043166 16439435
10. Park SH Kim CG Kim JY Choe JY Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment Rheumatol Int 2008, 28:475-477. 10.1007/s00296-007-0467-6 17943259
11. Thonhofer R Gaugg M Kriessmayr M Neumann HJ Erlacher L Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment Ann Rheum Dis 2005, 64:1098-1099. 1755549 15958773 10.1136/ard.2004.026252
12. Boubenider S Hiesse C Goupy C Kriaa F Marchand S Charpentier B Incidence and consequences of post-transplantation lymphoproliferative disorders J Nephrol 1997, 10:136-145. 9238621
13. Hislop AD Annels NE Gudgeon NH Leese AM Rickinson AB Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection J Exp Med 2002, 195:893-905. 2193726 11927633 10.1084/jem.20011692
14. Dunne PJ Faint JM Gudgeon NH Fletcher JM Plunkett FJ Soares MV Hislop AD Annels NE Rickinson AB Salmon M Akbar AN Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential Blood 2002, 100:933-940. 10.1182/ blood-2002-01-0160 12130505
15. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS Medsger TA Mitchell DM Neustadt DH Pinals RS Schaller JG Sharp JT Wilder RL Hunder GG The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
16. Dougados M Linden van der S Juhlin R Huitfeldt B Amor B Calin A Cats A Dijkmans B Olivieri I Pasero G Veys E Zeidler H The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy Arthritis Rheum 1991, 34:1218-1227. 10.1002/art.1780341003 1930310
17. Garrett S Jenkinson T Kennedy LG Whitelock H Gaisford P Calin A A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index J Rheumatol 1994, 21:2286-2291. 7699630
18. Samri A Durier C Urrutia A Sanchez I Gahery-Segard H Imbart S Sinet M Tartour E Aboulker JP Autran B Venet A Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay Clin Vaccine Immunol 2006, 13:684-697. 1489560 16760328 10.1128/CVI.00387-05
19. Yang J Lemas VM Flinn IW Krone C Ambinder RF Application of the ELISPOT assay to the characterization of CD8(+) responses to Epstein-Barr virus antigens Blood 2000, 95:241-248. 10607708
20. Steven NM Annels NE Kumar A Leese AM Kurilla MG Rickinson AB Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response J Exp Med 1997, 185:1605-1617. 2196300 9151898 10.1084/jem.185.9.1605
21. Doisne JM Urrutia A Lacabaratz-Porret C Goujard C Meyer L Chaix ML Sinet M Venet A CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection J Immunol 2004, 173:2410-2418. 15294954
22. Besson C Amiel C Le-Pendeven C Brice P Ferme C Carde P Hermine O Raphael M Abel L Nicolas JC Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives J Clin Microbiol 2006, 44:47-50. 1351946 16390946 10.1128/JCM.44.1.47-50.2006
23. Balandraud N Meynard JB Auger I Sovran H Mugnier B Reviron D Roudier J Roudier C Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real-time polymerase chain reaction Arthritis Rheum 2003, 48:1223-1228. 10.1002/ art.10933 12746895
24. Alvarez-Lafuente R Fernandez-Gutierrez B de Miguel S Jover JA Rollin R Loza E Clemente D Lamas JR Potential relationship between herpes viruses and rheumatoid arthritis: Analysis with quantitative real time polymerase chain reaction Ann Rheum Dis 2005, 64:1357-1359. 1755640 16100341 10.1136/ard.2004.033514
25. Klatt T Ouyang Q Flad T Koetter I Buhring HJ Kalbacher H Pawelec G Muller CA Expansion of peripheral CD8+ CD28-T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis J Rheumatol 2005, 32:239-251. 15693083
26. Lunemann JD Frey O Eidner T Baier M Roberts S Sashihara J Volkmer R Cohen JI Hein G Kamradt T Munz C Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis J Immunol 2008, 181:991-1000. 18606650
27. Reijasse D Le Pendeven C Cosnes J Dehee A Gendre JP Nicolas JC Beaugerie L Epstein-Barr virus viral load in Crohn's disease: Effect of immunosuppressive therapy Inflamm Bowel Dis 2004, 10:85-90. 10.1097/ 00054725-200403000-00004 15168806
28. Torre-Cisneros J Del Castillo M Caston JJ Castro MC Perez V Collantes E Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis Rheumatology (Oxford) 2005, 44:1132-1135. 10.1093/rheumatology/keh696 15927999
29. Balandraud N Guis S Meynard JB Auger I Roudier J Roudier C Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase Epstein-Barr virus load in patients with rheumatoid arthritis Arthritis Rheum 2007, 57:762-767. 10.1002/art.22783 17530675
30. Smets F Latinne D Bazin H Reding R Otte JB Buts JP Sokal EM Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease Transplantation 2002, 73:1603-1610. 10.1097/ 00007890-200205270-00014 12042647
31. Hamdi H Mariette X Godot V Weldingh K Hamid AM Prejean MV Baron G Lemann M Puechal X Breban M Berenbaum F Delchier JC Flipo RM Dautzenberg B Salmon D Humbert M Emilie D Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists Arthritis Res Ther 2006, 8:R114. 1779425 16859506 10.1186/ar1994